ARMC10P1

Across TCGA pan-cancer cohorts, ARMC10P1 RNA is linked to patient survival in 21 of 34 cancer types, making it the most broadly survival-associated ARMC10P1 data layer.

The strongest signal is observed in pancreatic adenocarcinoma (PAAD), where higher ARMC10P1 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated ARMC10P1 expression acts as an unfavorable survival marker, although some lineages such as THCA and SKCM show a favorable association.

PAAD, KICH, and THCA are the cancer types where ARMC10P1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
PAAD	DFS	Median	All	0.384	0.584	<.001	63	view →
KICH	DFS	Tertile	II,III,IV	0.448	0.934	.005	46	view →
THCA	OS	Median	III,IV	0.988	0.888	.001	38	view →
SKCM	DFS	Median	III,IV	0.406	0.185	.006	28	view →
ACC	DFS	Quartile	All	0.526	0.812	.006	16	view →
THYM	DFS	Median	II,III,IV	0.982	0.804	.003	14	view →
KIRP	DFS	Median	II,III,IV	0.319	0.646	.008	14	view →
LUSC	DFS	Quartile	All	0.831	0.701	.011	13	view →
COAD	DFS	Quartile	III,IV	0.961	0.629	.006	13	view →
ESCA	OS	Tertile	IV	0.206	0.856	.038	12	view →
OV	OS	Quartile	III,IV	0.301	0.407	.018	10	view →
CHOL	DFS	Tertile	III,IV	0.172	0.779	.024	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 21 lineages.

ARMC10P1–PAAD (DFS)

Open the PAAD breakdown →